Few Indian consumer brands have grown as quickly as Innovist. The beauty and personal care company behind Bare Anatomy and Chemist at Play nearly tripled its revenue in the 2025-26 financial year and swung to a solid profit, according to regulatory filings reported by Entrackr on October 20, months after agreeing to sell a majority stake to French cosmetics giant L'Oréal.
Revenue from operations rose to ₹685.7 crore in FY26 from ₹246.7 crore in FY25. Product sales accounted for ₹676.3 crore of the total, up from ₹239.1 crore, with other operating revenue such as shipping and scrap sales contributing ₹9.4 crore.
The company recorded a profit before tax of ₹30.5 crore, compared with a loss before tax of ₹55 lakh a year earlier. After a tax expense of ₹8.9 crore, including ₹7.8 crore of deferred tax, net profit stood at ₹21.5 crore.
Founders and the L'Oréal deal
Innovist was founded in 2019 by Rohit Chawla, Sifat Khurana and Vimal Bhola. In June 2026, L'Oréal agreed to acquire a majority stake in the company, according to Indian Retailer. Under the deal, the founders will remain minority shareholders and continue to lead the business alongside L'Oréal India, and L'Oréal has secured rights to acquire the remaining shares later. The transaction was expected to close over the following months, subject to regulatory approvals and customary conditions. The deal value was not disclosed.
For Khurana, one of a small number of women co-founders to build an Indian consumer brand to this scale, the deal represents a striking validation. Women founders and co-founders have been particularly active in India's beauty and personal care sector, where women make up a large share of customers, and where understanding consumer needs, ingredients and formulations is central to building trust.
The L'Oréal transaction is one of the most significant acquisitions of an Indian digital-first beauty brand by a global group, and it adds to a growing list of exits in the sector as multinational companies look to tap India's fast-growing beauty market.
The cost of rapid growth
Innovist's growth has required heavy investment in marketing. Advertising and promotional expenses rose to ₹262 crore in FY26 from ₹84.2 crore, about 38% of operating revenue. Commissions paid to sole selling agents increased to ₹92 crore from ₹15 crore, reflecting the expansion of distribution through partners.
Total expenses rose to ₹662 crore from ₹250 crore. The cost of materials consumed nearly doubled to ₹162 crore, while employee benefit expenses doubled to ₹39 crore.
Despite these costs, Innovist managed to turn profitable as revenue grew faster than expenses, a notable achievement in a category where many brands have struggled to balance growth and profitability. At the end of FY26, the company held current assets of ₹303 crore, including ₹81 crore in cash and bank balances.

How Innovist built its brands
Innovist, which operates through Onesto Labs, develops skincare and haircare products and manufactures them in India. Bare Anatomy focuses on personalised haircare and skincare solutions, while Chemist at Play offers ingredient-led products, including body care and sun care, aimed at younger consumers.
The company sells through online marketplaces, its own websites and third-party offline stores, and has expanded into quick commerce, where fast delivery of beauty products has become increasingly popular in Indian cities. Its multichannel strategy reflects a broader shift among digital-first brands towards omnichannel distribution as they seek to reach consumers beyond the internet.



